Novartis Pharma Stein AG (manufacturing, quality control, primary packaging, secondary packaging)

The drug is used to prevent the rejection of transplanted organs (kidneys, liver, heart, lungs, pancreas) and bone marrow. It is also used to treat established graft rejection or graft-versus-host disease (GVHD).

Dosage form: concentrate for infusion solution

ATC: L04AD01